Giuseppe Grasso

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 290 citations

Medicine, Endocrinology, Pharmacology +11

miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer

Andrea Sacconi, Francesca Biagioni, Valeria Canu et al. · Cell Death and Disease · 2012 · 181 citations · Full text

Medicine, Cancer Biology, Oncology +17

Detection of an Activating Mutation of the Thyrotropin Receptor in a Case of an Autonomously Hyperfunctioning Thyroid Insular Carcinoma1

Diego Russo, Franco Arturi, Paolo Vigneri et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 108 citations · Full text

Medicine, Endocrinology, Oncology +17

miR‐10b*, a master inhibitor of the cell cycle, is down‐regulated in human breast tumours

Francesca Biagioni, Noa Bossel Ben‐Moshe, Giulia Fontemaggi et al. · EMBO Molecular Medicine · 2012 · 95 citations · Full text

Medicine, Molecular Biology, Oncology +16

A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy

M Lunetta, Rosario Le Moli, Giuseppe Grasso et al. · Diabetes Research and Clinical Practice · 1998 · 90 citations

Medicine, Internal Medicine, Neurology +14